comScore Investor Presentation — April 2021

Document content

its shock- absorbing capacity

once again in Q1 2021SCOR

Numbers presented throughout this document may not add up precisely to the totals in the tables and text. Percentages and per cent changes are calculated on complete figures (including decimals); therefore, the

document might contain immaterial differences in sums and percentages due to rounding. Unless otherwise specified, the sources f or the business ranking and market positions are internal.

Forward- looking statements

This document includes forward- looking statements and information about the objectives of SCOR, in particular, relating to its c urrent or future projects. These statements are sometimes identified by the use of the future

tense or conditional mode, as well as terms such as “estimate”, “believe”, “have the objective of”, “intend to”, “expect”, “r esult in”, “should” and other similar expressions. It should be noted that the achievement of these

objectives and forward- looking statements is dependent on the circumstances and facts that arise in the future.

Forward- looking statements and information about objectives may be impacted by known and unknown risks, uncertainties and other factors that may significantly alter the future results, performance and

accomplishments planned or expected by SCOR.

The full impact of the Covid- 19 crisis on SCOR’s business and results can still not be accurately assessed at this stage, given the uncertainty related both to the magnitude and duration of the Covid- 19 pandemic and to

the possible effects of future governmental actions and/or legal developments in this context. This uncertainty follows from theconsiderable difficulty in working on sound hypotheses on the impact of this crisis due to the

lack of comparable events, the ongoing nature of the pandemic and its far -reaching impacts on the global economy, on the health of the population and on our customers and counterparties.

These hypotheses include, in particular:

•the duration of the pandemic, its impact on health on the short and long term,

•the availability, efficacy, effectiveness and take- up rate and effect of the vaccines;

•the response of government bodies worldwide (including executive, legislative and regulatory);

•the potential judicial actions or social influences;

•the coverage and interpretation of SCOR’s contracts under these circumstances;

•the assessment of the net claim estimates and impact of claim mitigation actions.

•any assessments and resulting figures presented in this document will necessarily be rough estimates based on evolving analys es,and encompass a wide range of theoretical hypotheses, which are still highly